Sabra Healthcare REIT (NASDAQ:SBRA) Releases FY 2026 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.530-1.550 for the period, compared to the consensus EPS estimate of 1.500. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

SBRA has been the topic of a number of research reports. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Wells Fargo & Company upped their price objective on Sabra Healthcare REIT from $22.00 to $23.00 and gave the company an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings cut Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Truist Financial upgraded Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 target price on the stock in a research note on Wednesday, July 8th. Finally, Cantor Fitzgerald upped their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $21.45.

Sabra Healthcare REIT Trading Up 10.2%

NASDAQ SBRA opened at $22.04 on Wednesday. The stock has a market capitalization of $5.56 billion, a P/E ratio of 34.98, a P/E/G ratio of 1.49 and a beta of 0.65. Sabra Healthcare REIT has a 52-week low of $17.17 and a 52-week high of $22.10. The firm has a 50-day moving average price of $19.61 and a 200 day moving average price of $19.78. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million for the quarter, compared to analyst estimates of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s revenue for the quarter was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 5.4%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Smartleaf Asset Management LLC lifted its position in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 714 shares during the period. Danske Bank A S acquired a new position in Sabra Healthcare REIT during the third quarter worth $30,000. Larson Financial Group LLC boosted its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock worth $35,000 after purchasing an additional 553 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after purchasing an additional 1,536 shares during the last quarter. Finally, Quarry LP purchased a new position in shares of Sabra Healthcare REIT in the third quarter valued at $48,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.